Early Viral Response Predicts the Efficacy of Antiviral Triple Therapy with Simeprevir, Peg-Interferon and Ribavirin in Patients Infected with Hepatitis C Virus Genotype 1

By  

Digestive Diseases, Vol. 33, Iss. 6, 2015-0 ,pp. : 708-714

Karger

Access to resources Recommend Favorite

Retreatment of chronic hepatitis C with ribavirin followed by interferon

By Bellobuono A.   Mondazzi L.   Tempini S.   Silini E.   Vicari F.   Asti L.   Zavaglia C.   Ideo G.  

International Hepatology Communications, Vol. 7, Iss. 2, 1997-06 ,pp. : 121-129

Elsevier

Access to resources Recommend Favorite

Chronic Hepatitis C and Crohn’s Disease: Nosocomial Infection Treatment with PEG-Interferon plus Ribavirin

By  

Digestion, Vol. 73, Iss. 4, 2006-09 ,pp. : 210-214

Karger

Access to resources Recommend Favorite

Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C

By Tohra S.  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2449-2455

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy

By Arase Yasuji   Ikeda Kenji   Tsubota Akihito   Suzuki Yoshiyuki   Saitoh Satoshi   Kobayashi Masahiro   Suzuki Fumitaka   Akuta Norio   Someya Takashi   Hosaka Tetsuya   Kobayashi Mariko   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 39, Iss. 5, 2004-05 ,pp. : 455-460

Springer Publishing Company

Access to resources Recommend Favorite